MEF2A

MEF2A myocyte enhancer factor 2A

MEF2A; myocyte enhancer factor 2A; myocyte-specific enhancer factor 2A; serum response factor-like protein 1; MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A); mef2; ADCAD1; RSRFC4; RSRFC9;

MEF2D

myocyte enhancer factor 2D

MEF2D; myocyte enhancer factor 2D; myocyte-specific enhancer factor 2D; MEF2D/DAZAP1 fusion; MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D); myocyte enhancer factor 2D/deleted in azoospermia associated protein 1 fusio;

MYOC

myocilin, trabecular meshwork inducible glucocorticoid response

MYOC; myocilin, trabecular meshwork inducible glucocorticoid response; GLC1A; myocilin; JOAG1; TIGR; mutated trabecular meshwork-induced glucocorticoid response protein; GPOA; JOAG;

MEF2C

myocyte enhancer factor 2C

MEF2C; myocyte enhancer factor 2C; myocyte-specific enhancer factor 2C; MADS box transcription enhancer factor 2, polypeptide C; C5DELq14.3; DEL5q14.3;

EPM2A

epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)

EPM2A; epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); epilepsy, progressive myoclonus type 2, Lafora disease (laforin); laforin; LD; LDE; LAFPTPase; lafora PTPase; EPM2; MELF;

MEF2B

myocyte enhancer factor 2B

MEF2B; myocyte enhancer factor 2B; myocyte-specific enhancer factor 2B; RSRFR2; serum response factor-like protein 2; MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B); FLJ32648;

MYOCD

myocardin

MYOCD; myocardin; MYCD; MYCD_HUMAN; transcription factor myocardin;

MKL2

MKL/myocardin-like 2

MKL2;MKL/myocardin-like 2;29819;ENSG00000186260;MRTF-B;NPD001;16p13.12;FLJ31823, FLJ45623, DKFZp686J1745;MKL/myocardin-like protein 2;MKL/myocardin-like protein 2;megakaryoblastic leukemia 2;myocardin-related transcription factor B;

Myzap

myocardial zonula adherens protein

Laforin

epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)

EPM2; MELF;